Guido Bocci

University of Pisa
Department of Clinical and Experimental Medicine
Papers:
FP34-4 A novel multi-target pyrazolopyrimidine derivative with anti-neoplastic properties is active against medullary thyroid cancer in vitro and in vivo: CLM29